Mayne Pharma Group Ltd Cash Flow Quality Index
Mayne Pharma Group Ltd cash flow quality index. Mayne Pharma Group Ltd (MYX) has a Cash Flow Quality Index of -0.20x as of September 2022. Operating cash flow of AU$-28.40 Million is below net income of AU$145.01 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Mayne Pharma Group Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Mayne Pharma Group Ltd (2010–2023)
Cash flow quality index of Mayne Pharma Group Ltd from 2010 to 2023. Historical Cash Flow Quality Index for Mayne Pharma Group Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. See MYX net asset quality index to measure how much of total assets are equity-financed.
Mayne Pharma Group Ltd Cash Flow Quality Index by Year (2010–2023)
Mayne Pharma Group Ltd cash flow quality index by year from 2010 to 2023. Year-by-year earnings quality comparison for Mayne Pharma Group Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Mayne Pharma Group Ltd.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.36x | AU$-42.71 Million | AU$117.25 Million | ▼ -111.7% |
| 2017 | -0.17x | AU$-15.24 Million | AU$88.57 Million | ▼ -112.0% |
| 2016 | 1.43x | AU$53.50 Million | AU$37.35 Million | ▼ -50.4% |
| 2015 | 2.89x | AU$22.42 Million | AU$7.76 Million | ▲ +135.4% |
| 2014 | 1.23x | AU$26.14 Million | AU$21.29 Million | ▼ -43.6% |
| 2012 | 2.18x | AU$13.39 Million | AU$6.15 Million | ▼ -10.6% |
| 2011 | 2.43x | AU$4.09 Million | AU$1.68 Million | ▼ -22.8% |
| 2010 | 3.15x | AU$10.26 Million | AU$3.25 Million | — |